Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty

Condition:   Peripheral Arterial Disease Interventions:   Biological: G-CSF + CD133(+) cells;   Biological: G-CSF;   Procedure: percutaneous transluminal angioplasty (PTA);   Biological: Placebo infusion Sponsor:   Shanghai 10th People's Hospital Recruiting - verified September 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials